Yuhan to market Zirtec

Yuhan Corporation said the company will market UCB’s popular antihistamine drug Zirtec (cetirizine) for the next five years here as it took over its marketing right from Samil Pharm.

Yuhan will step up their marketing in the domestic allergic treatment market, which is forecast to become more competitive than ever this year, according to industry sources.

"Yuhan is likely to expand their ...